suggested that the thrust areas in leprosy research would be a) development of new drugs to reduce the length of treatment and to treat drug resistant cases b) development of laboratory methods for identification of drug resistance c) development of suitable tests to detect cases at early stages of infection and for diagnosis of type I and type II reactions before their onset d) search for immunoprotective molecules for development of vaccines e) understanding the mechanism of anergy to M. leprae f) surgical research at microlevel to restore the functions of vital organs g) development of survey methodology for quick finding of hidden cases in the population and h) educating the community and establishing community based rehabilitation.
Tuberculosis remained as the single largest infectious killer disease in the world, inspite of the fact that it is curable and controllable. While there were 2.5 million deaths due to tuberculosis in 1990, this figure might reach to about 6 million in the year 2005. Tuberculosis control programme in India incorporated Directly Observed treatment, short-course (DOTS) for effective management of the infection. Stating this Dr.P.R. Narayanan emphasised the need to continue research in certain thrust areas like (a) development of new immunological/ molecular probe based assays for detection of people with early infection and for diagnosis of smear negative cases (b) understanding the genetic manipulations of mycobacteria related to virulence and drug resistance. (c) identification of host's genetic susceptibility factors (d) development of new vaccines and (e) identification of the possible dormant' bacilli in the population and on the failure of the host to evoke effective immune response against such bacilli.
Dr. P. Kumaraswamy pointed out that in the first instance there was lack of awareness of the problems related to the tropical diseases in the community and the funds provided to tackle these diseases were too scanty. Added to this there were no suitable rapid assessment procedures available for many of these diseases. The parasitological diagnosis of lymphatic filariasis was still based on a very tedious method of collection of night blood samples and their transport to a laboratory for processing and examination. This could cause much delay in identifying the microfilarial carriers and initiating drug therapy. The trained health workers who had no prior clinical knowledge were able to detect the number of lymphoedema cases in the field and assess the prevalence offilarial disease cases. Simple and crude method like this could as well be the rapid assessment tool. Applying such tools it would be posible to develop packages that could offer menu of appropriate strategies and measures for the control of different tropical diseases.
While noting that the positive outcome of research was not effectively passed on to the field for successful management of the unfortunate millions suffering from tropical diseases, Dr. G. Manokaran stressed the need to develop foolproof systems to screen the whole population for these health problems and to evoke a consensus way of treating them under one health policy system.
Participating in the discussion Dr. V.V. Dongre pointed to the lack of uniform drug schedules in treatment of leprosy cases and the necessity of finding novel techniques to prevent deformities associated with this disease. Dr. Jayashree Bhattacharya added that microvascular surgery centres were needed for the benefit of leprosy patients. Dr. Bhupinder Singh stressed the need of sustainability and community participation in implementing control measures for achieving the goals. The discussion ended with the chairperson thanking the panelists for their active participation and the organisers of the symposium for providing forum for the discussion. 
